MARKER THERAPEUTICS, INC. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2018-12-31 was $71.71K.
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2017-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for the quarter ending 2016-12-31 was $0.00.
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2018 was $71.71K, a 76.90% decline from fiscal 2017.
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2017 was $310.49K.
- MARKER THERAPEUTICS, INC. payments for repurchase of common stock for fiscal 2016 was $0.00.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2018-12-31 | $71.71K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $71.71K 10-K · filed 2020-03-12 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | $310.49K 10-K · filed 2019-03-15 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | $0.00 10-K · filed 2018-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |